Skip to content

Author

Brian Shuch

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Abstract A060: Targeting metabolic–DNA repair vulnerabilities in SDHB- and FH-deficient renal cell carcinoma with the novel alkylating agent KL-50

FH- and SDHB-mutant RCC is identified as a molecularly defined subset characterised by epigenetic MGMT silencing, which may confer selective vulnerability to KL-50, which has the potential to overcome resistance mechanisms that have historically constrained the clinical utility of TMZ in this disease context.

Suparna M. Basu, R. Sundaram, Brian Shuch et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.